Powered By
Certainly! Here are some molecular factors involved in diagnosing Chronic Lymphocytic Leukemia (CLL):
- Gene Mutations: Specific genes like TP53 and IgVH are often mutated in CLL cells. Identifying these mutations helps understand the prognosis
- Cytogenetic Tests: Tests like fluorescence in situ hybridization (FISH) and Show Full Answer
Thank you, Robert507. I have been frustrated by some outdated information and lack of information about the medication I am about to take, which is Brukinsa, other than on its own site.
We know that there are many different white blood cells. I never got a good answer from my doctor except "looks good?" I like to focus on the "T" and "B" cells. The B cells mark cells to be attacked by the T cells. I currently take medication to inactivate B and may be T cells. I have no il affects from the medication and my WBC count is 6900. I understand the biological and chemical reaction "BTK Inhibitor" response by the medication. I think we are in the 21st century and there are many medications for the many different types of leukemias. Some of the RESOURCE information is dated with incomplete answers for new treatments listed after 2020? My treatment was FDA approved 12/22 so it may or may not be listed in some articles?
Join
Your Privacy Choices
